col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


288 Ergebisse       Seite 1

 [1] 
Elsevier: Biophysical Journal
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Jul―05 Enzyme kinetics model for the coronavirus main protease including dimerization and ligand binding Van N.T. La, Lulu Kang, David D.L. Minh
2 [GO] 2025―Mai―19 An integrated multiscale computational framework deciphers SARS-CoV-2 resistance to sotrovimab Akshit Sharma, Shweata Maurya, Shivank Kumar, Timir Tripathi, Rajiv K. Kar, Aditya K. Padhi
3 [GO] 2025―Feb―13 BPS2025 - Anti-viral activities of host microRNA against the SARS-CoV-2 genome 3′ untranslated region David B. Heisler, Caleb J. Frye, Caylee Cunningham, Mihaela-Rita Mihailescu
4 [GO] 2025―Feb―13 BPS2025 - Structural insights into SARS-CoV-2 fusion domain: Role of BMP and helix extension in membrane fusion efficiency Jinwoo Lee
5 [GO] 2025―Feb―13 BPS2025 - Structural insights into SARS-CoV-2 fusion domain: Role of BMP and helix extension in membrane fusion efficiency Jinwoo Lee
6 [GO] 2025―Feb―13 BPS2025 - EPR spectroscopic characterization of the topology of SARS-CoV-2 envelope protein Andrew K. Morris
7 [GO] 2025―Feb―13 BPS2025 - Effects of indel mutations on non-conservative substitutions in the spike region between SARS-CoV-2 and its variants of concern, and how they affect their key mutations Bezaleel Akinbami, Roshan Paudel
8 [GO] 2025―Feb―13 BPS2025 - Constitutive macropinocytosis is the major entry pathway of SARS-CoV-2 Sue Han, Xin Wang, Tiansheng Li, Ammar Mohseni, Ivan Kosik, Chung Yu Chan, et al. (+6)
9 [GO] 2025―Feb―13 BPS2025 - Constitutive macropinocytosis is the major entry pathway of SARS-CoV-2 Sue Han, Xin Wang, Tiansheng Li, Ammar Mohseni, Ivan Kosik, Chung Yu Chan, et al. (+6)
10 [GO] 2025―Feb―13 BPS2025 - De-novo designed mini-protein binders against the nucleocapsid protein of SARS-CoV-2 Zeenat Khaker Wala, Ashwani Kumar, Biplab Ghosh, Ravindra D. Makde
11 [GO] 2025―Feb―13 BPS2025 - Structural design and characterization of prefusion-stabilized coronavirus S2 proteins in complex with antibodies Adonis Rubio, Morgan Abernathy, Yu Lee, Michael Eso, Davide Robbiani, Christopher O. Barnes
12 [GO] 2025―Feb―13 BPS2025 - Characterization of bat coronavirus spike glycoprotein dynamics via molecular dynamics simulations Toheeb A. Balogun, Cory M. Acreman, Fiona L. Kearns, Alexandra L. Tse, Gorka Lasso, Emily H. Miller, et al. (+3)
13 [GO] 2025―Feb―13 BPS2025 - Characterization of bat coronavirus spike glycoprotein dynamics via molecular dynamics simulations Toheeb A. Balogun, Cory M. Acreman, Fiona L. Kearns, Alexandra L. Tse, Gorka Lasso, Emily H. Miller, et al. (+3)
14 [GO] 2025―Feb―13 BPS2025 - Rate-limiting steps of coronavirus fusion Tobin Hess, Oyinkansola Adenekan, Marcos Cervantes, Peter Kasson
15 [GO] 2025―Feb―13 BPS2025 - Rate-limiting steps of coronavirus fusion Tobin Hess, Oyinkansola Adenekan, Marcos Cervantes, Peter Kasson
16 [GO] 2025―Feb―13 BPS2025 - Cardiac voltage-gated sodium channels are a common pathological pathway in COVID-19-induced arrhythmia Mohamed A. Fouda, Yasmine Fathy Mohamed, Rachel Fernandez, Peter C. Ruben
17 [GO] 2025―Feb―13 BPS2025 - Mechanism of SARS-CoV-2 nucleocapsid protein phosphorylation-induced functional switch Ioulia F. Rouzina, Megan Sullivan, Michael Morse, Micah J. McCauley, Dina Bayachou, Jana Sefcikova, et al. (+3)
18 [GO] 2025―Feb―13 BPS2025 - Mechanism of SARS-CoV-2 nucleocapsid protein phosphorylation-induced functional switch Ioulia F. Rouzina, Megan Sullivan, Michael Morse, Micah J. McCauley, Dina Bayachou, Jana Sefcikova, et al. (+3)
19 [GO] 2025―Feb―13 BPS2025 - SARS-CoV-2 nucleocapsid protein nonspecifically interacts with and folds dsDNA Jonathan Xing, Ashley Carter
20 [GO] 2025―Feb―13 BPS2025 - Interaction of human hnRNPA1 with SARS-CoV-2 nucleocapsid protein and its implications for viral RNA binding Parul Gupta
21 [GO] 2025―Feb―13 BPS2025 - Curvature induction and membrane-mediated interactions of the SARS-CoV-2 membrane protein Joseph McTiernan, Michael E. Colvin, Ajay Gopinathan
22 [GO] 2025―Feb―13 BPS2025 - Unraveling the catalytic mechanism of the SARS-CoV-2 macrodomain ADP-ribosylhydrolase Rishav Mitra, Galen Correy, James Fraser
23 [GO] 2025―Feb―13 BPS2025 - Computational targeting of key ACE2 regions by Rhynchophorus palmarum fatty acids: Molecular dynamics insights for SARS-CoV-2 inhibition Tanisque Verma, Santiago Ballaz, Daniel Lituma-González, Shruti Balamurugen, Saravana Prakash Thirumuruganandham
24 [GO] 2025―Feb―13 BPS2025 - Exploring nodding dynamics of SARS-CoV-2 prefusion spike head in variants of concern by developing symmetry-information-loaded structure-based model Anushree Sinha, Susmita Roy
25 [GO] 2025―Feb―13 BPS2025 - Differential kinetics of SARS-CoV-2 proteases revealed by a dual-color BRET-based protease biosensor DuProSense Asma Fatima, Anupriya M. Geethakumari, S.M. Uddin, Kabir H. Biswas
26 [GO] 2025―Feb―13 BPS2025 - Unravelling the interaction between perlecan LG3 and the SARS-CoV-2 spike protein Md Lokman Hossen, Timothy E. Gressett, Grant Talkington, Milla Volic, Hugo Perez, Purushottam B. Tiwari, et al. (+2)
27 [GO] 2025―Feb―13 BPS2025 - Microsecond timescale single-molecule dynamics of SARS-CoV-2 spike protein using diffracted X-ray tracking Daisuke Sasaki, Hiroshi Sekiguchi, Kazuhiro Mio, Yuji C. Sasaki
28 [GO] 2025―Feb―13 BPS2025 - Microsecond timescale single molecule dynamics of SARS-CoV-2 spike protein using diffracted X-ray tracking Daisuke Sasaki, Hiroshi Sekiguchi, Kazuhiro Mio, Yuji C. Sasaki
29 [GO] 2025―Feb―13 BPS2025 - Structure and inhibition of SARS-CoV-2 spike refolding in membranes Walther Mothes, Mikey W. Grunst, Zhuan Qin, Esteban Dodero-Rojas, Shilei Ding, Jeremie Prevost, et al. (+9)
30 [GO] 2025―Feb―13 BPS2025 - Conformational flexibility and binding mechanism of SARS-CoV-2 spike variants Rong Zhu, Sarah Stainer, Manuel Reithofer, Mateusz Sikora, Daniel Canena, Hannah Seferovic, et al. (+9)
31 [GO] 2025―Feb―13 BPS2025 - Structural insights into the molecular mechanism of broad-spectrum neutralization of SARS-CoV-2 variants by bnAbs Bingjie Tang
32 [GO] 2024―Mai―06 Reconstruction of the real 3D shape of the SARS-CoV-2 virus Fadoua Balabdaoui, Tomasz Wierzbicki, Emma Bao
33 [GO] 2024―Mrz―16 Testing the feasibility of targeting a conserved region on the S2 domain of the SARS-CoV-2 spike protein Pranav Garg, Shawn C.C. Hsueh, Steven S. Plotkin
34 [GO] 2024―Feb―08 A search for anti-SARS-CoV-2 compounds for the treatment of COVID-19 infection using chemical similarity analysis Siwar Khasawneh, Roshan Paudel
35 [GO] 2024―Feb―08 Cardiac pathophysiology of COVID-19 mediated by ryanodine receptor type 2 Ca2+ leak Laith Bahlouli, Steven Reiken, Haikel Dridi, Andrew R. Marks
36 [GO] 2024―Feb―08 Comprehensive analysis of spike protein mutations in coronavirus subvariants reveals newly emerging change in mode of entry and establishment of infection in hosts Asmaa Awan, Roshan Paudel
37 [GO] 2024―Feb―08 SARS-CoV-2 nsp3 C-terminal region: Conserved beyond coronavirus with potential role in DMV pore formation Yulia Pustovalova, Alexandra Pozhidaeva, Jeffrey C. Hoch
38 [GO] 2024―Feb―08 SARS-CoV-2 binding to terminal sialic acid of gangliosides embedded in lipid membranes Geetanjali Negi
39 [GO] 2024―Feb―08 EPR spectroscopic characterization of the topology of SARS-CoV-2 envelope protein Andrew K. Morris, Gary A. Lorigan
40 [GO] 2024―Feb―08 CIS-mediated interactions of the SARS-CoV-2 frameshift RNA alter its conformations and affect function Lukas Pekarek, Matthias Zimmer, Anne-Sophie Gribling-Burrer, Patrick Bohn, Redmond P. Smyth, Neva Caliskan
41 [GO] 2024―Feb―08 Mitochondrial network physiology disruption during SARS-CoV-2 infection in human lung organoids Gillian McMahon, Zichen Wang, Hiroyuki Hakozaki, Paul Marchando, Cyna R. Shirazinejad, Yuichiro Iwamoto, et al. (+4)
42 [GO] 2024―Feb―08 The role of heparin in spike SARS-CoV-2 infection: From a model for heparan sulfates to a starting structure for antivirals Giulia Paiardi, Maria Milanesi, Matheus Ferraz, Liv Zimmermann, Chiara Urbinati, Pasqua Oreste, et al. (+4)
43 [GO] 2024―Feb―08 Synthesis and characterization of SARS-CoV-2 membrane protein Sara Anbir, Yuanzhong Zhang, Thomas E. Kuhlman, Michael E. Colvin, Ajay Gopinathan, Umar Mohideen, et al. (+4)
44 [GO] 2024―Feb―08 The role of ATP hydrolysis and product release in the translocation mechanism of SARS-CoV-2 nsp13 Priti Roy, Monsurat M. Lawal, Martin McCullagh
45 [GO] 2024―Feb―08 Expanding our knowledge of the SARS-CoV-2 polyproteins: Structural and biochemical insights into the viral processing Ruchi Yadav, Valentine V. Courouble, Sanjay K. Dey, Jerry Joe E.K. Harrison, Jennifer Timm, Jesse B. Hopkins, et al. (+5)
46 [GO] 2024―Feb―08 Structural insights into cross-reactive antibodies recognizing the N-terminal and receptor binding domains of the SARS-CoV-2 spike glycoprotein Adonis Rubio, Morgan Abernathy, Yu Erica Lee, Teresia Chen, Christopher O. Barnes
47 [GO] 2024―Feb―08 Novel SARS-CoV-2 VLP system and structural characterization by cryogenic electron tomography reveals orf3A and orf7A accessory proteins as critical for assembly Juliana Abramovich
48 [GO] 2024―Feb―08 Optimization and applications of a compact stem-loop DNA aptamer targeting SARS-CoV-2 nucleocapsid protein Morgan Esler, Christopher Belica, Arad Moghadasi, Ke Shi, Mackenzie Wyllie, Daniel A. Harki, et al. (+2)
49 [GO] 2024―Feb―08 Structural restraints in the SARS-CoV-2 spike tail control its intra-cellular trafficking to virion assembly and immune presentation sites Syed Saif Hasan, Debajit Dey, Suruchi Singh, Enya Qing, Yanan He, Yihong Chen, et al. (+9)
50 [GO] 2024―Feb―08 Common cold coronavirus (CoV229E) infections alters 3D genomic architecture Ankush Singhal, Cullen Roth, Sofiya Micheva-Viteva, Vrinda Venu, Christina Steadman, Shawns Starkenburg, Karissa Y. Sanbonmatsu
51 [GO] 2024―Feb―08 Adsorption of pulmonary surfactants on the spike proteins of SARS-CoV-2 and its variants Kolattukudy P. Santo, Ryan Jaworski, Alexander Neimark
52 [GO] 2024―Feb―08 The effect of lipid and protein flexibility on membrane deformations caused by the SARS-CoV-2 E protein Jesse W. Sandberg, Grace H. Brannigan
53 [GO] 2024―Feb―08 Flipped over u: Structural basis for dsRNA cleavage by the SARS-CoV-2 endoribonuclease Meredith N. Frazier, Monica Pillon, Lucas Dillard, Juno Krahn, Isha Wilson, Jason Williams, et al. (+5)
54 [GO] 2024―Feb―08 The SARS-CoV-2 envelope protein channel displays weak selectivity and heterogeneous oligomerization Vicente M. Aguilella, Maria Queralt-Martin, Wahyu Surya, Ernesto Tavares Neto, Andrea Sanchis, Antonio Alcaraz, Jaume Torres
55 [GO] 2024―Feb―08 Investigating how the anionic lipid, BMP, plays a crucial role in the initation of SARS-CoV-2 fusion Daniel Birtles
56 [GO] 2024―Feb―08 Reversal of the fusion catalytic role of SARS-CoV-2 fusion peptide by restricting the N terminus: Implications to tackle viral infection Avijit Sardar, Tapas Bera, Santosh K. Samal, Samit Guha, Pradip K. Tarafdar
57 [GO] 2024―Feb―08 An efficient protocol for accurately triaging molecules in the development of a SARS-CoV-2 main protease inhibitor Alexander M. Payne, Benjamin Kaminow, John D. Chodera
58 [GO] 2024―Feb―08 Revealing membrane factors that control SARS-CoV-2 membrane fusion and entry kinetics Marcos Cervantes, Tobin Hess, Peter Kasson
59 [GO] 2024―Feb―08 Molecular dynamics simulations of the SARS-CoV-2 membrane protein and its implications for viral assembly Joseph McTiernan, Ajay Gopinathan, Michael E. Colvin
60 [GO] 2024―Feb―08 Interactions of SARS-CoV-2 nsp7 or nsp8 with nsp12 causes severe constriction of RNA entry channel: Implications for novel RdRp inhibitor drug discovery Deepa Singh, Tushar Kushwaha, Rajkumar Kulandaisamy, Vikas Kumar, Kamal Baswal, Saras H. Tiwari, et al. (+3)
61 [GO] 2024―Feb―08 DNA folding by SARS-CoV-2 nucleocapsid protein Jonathan Xing, Youna J. Choi, Ashley Carter
62 [GO] 2024―Feb―08 Single-molecule spectroscopy of the SARS-CoV-2 nucleocapsid protein Jasmine Cubuk, J. Jeremias Incicco, Melissa D. Stuchell-Brereton, Kathleen B. Hall, Andrea Soranno
63 [GO] 2024―Feb―08 Phosphorylation regulates the function of the SARS-COV-2 nucleocapsid protein Bruna Favetta, Huan Wang, Mayur Barai, Bineet Sharma, Cesar Ramirez, Gabriela Tirado-Mansilla, et al. (+4)
64 [GO] 2024―Feb―08 Impact of crowding on conformations and interactions of the SARS-CoV-2 nucleocapsid protein and RNA Madison Stringer, Jasmine Cubuk, Jeremias Incicco, Debjit Roy, Kathleen B. Hall, Melissa D. Stuchell-Brereton, Andrea Soranno
65 [GO] 2024―Feb―08 The evolving biophysics and antigenicity of the SARS-CoV-2 Omicron spike receptor binding domain Jared Lindenberger, Chan Soo Park, Salam Sammour, Xiao Huang, Katarzyna Janowska, Priyamvada Acharya
66 [GO] 2024―Feb―08 Computational investigations of SARS-CoV-2 proofreading exoribonuclease (ExoN) suggest strategies for antiviral design Eleonora Gianti
67 [GO] 2024―Feb―08 Localization of viral RNA and proteins in the SARS-CoV-2 replication organelles revealed by super-resolution microscopy Leonid Andronov, Mengting Han, Yanyu Zhu, Anish R. Roy, Andrew E.S. Barentine, Lei S. Qi, William E. Moerner
68 [GO] 2024―Feb―08 Harnessing molecular simulations to design stabilized SARS-CoV-2 S2 antigens Lorenzo Casalino, Xandra Nuqui, Ling Zhou, Mohamed Shehata, Albert Wang, Alexandra L. Tse, et al. (+9)
69 [GO] 2024―Feb―08 Real-time visualization of intermolecular interactions between SARS-CoV-2 spike protein and NTD-binding antibody using high-speed atomic force microscopy Pangmiaomiao Zhang, Chia-Wei Chou, Ilya J. Finkelstein, Yi-Chih Lin
70 [GO] 2024―Feb―08 An implicit dye sampling technique for the study of conformational dynamics of SARS-CoV-2 spike protein variants Joseph Williamson, Maolin Lu, Mahmoud Moradi
71 [GO] 2024―Feb―08 Structures and stability of SARS-CoV-2 spike S2 subunit mutants targeting inter-subunit interactions Ruth J. Parsons, Alexandria Calloway, Ellie Zhang, Bhishem Thakur, Katarzyna Janowska, Priyamvada Acharya
72 [GO] 2024―Feb―08 Biophysical principles predict fitness of SARS-CoV-2 variants Dianzhuo Wang, Marian Huot, Vaibhav Mohanty, Eugene Shakhnovich
73 [GO] 2024―Feb―08 Role of the proton-activated chloride channel in SARS-CoV-2 viral entry Nicholas R.M. Koylass, Henry Yi Cheng, Kevin Chen, Zhaozhu Qiu
74 [GO] 2024―Feb―08 Host microRNA interactions with the SARS-COV-2 viral genome 3′-untranslated region Caleb J. Frye, Caylee Cunningham, Mihaela-Rita Mihailescu
75 [GO] 2024―Feb―08 Investigating spike S2 subunit hairpin proteins of the SARS-CoV-2 virus Noel Chau, Rob Wolfe, Gavin Engweiler, David P. Weliky
76 [GO] 2024―Feb―08 Cooperativity and induced oligomerization control the interaction of SARS-CoV-2 with its cellular receptor and patient-derived antibodies Roi Asor, Anna Olerinyova, Sean A. Burnap, Manish S. Kushwah, Mario Hensen, Snežana Vasiljevic, et al. (+9)
77 [GO] 2024―Feb―08 Capturing the biomechanics of SARS-COV-2/antibody complexes by GōMartini simulation Luis F. Cofas-Vargas, Adolfo Poma
78 [GO] 2024―Jan―17 Targeting protein-protein interaction interfaces with anti-viral N protein inhibitor in SARS-CoV-2 Jhen-Yi Hong, Shih-Chao Lin, Kylene Kehn-Hall, Kai-Min Zhang, Shun-Yuan Luo, Hung-Yi Wu, et al. (+2)
79 [GO] 2023―Okt―28 Biophysical evolution of the receptor binding domains of SARS-CoVs Vaibhav Upadhyay, Sudipta Panja, Alexandra Lucas, Casey Patrick, Krishna M.G. Mallela
80 [GO] 2023―Sep―16 Structure adaptation in Omicron SARS-CoV-2/hACE2: Biophysical origins of evolutionary driving forces Ya-Wen Hsiao, David J. Bray, Tseden Taddese, Guadalupe Jiménez-Serratos, Jason Crain
81 [GO] 2023―Mrz―24 Loading dynamics of one SARS-CoV-2-derived peptide into MHC-II revealed by kinetic models Kaiyuan Song, Honglin Xu, Lin-Tai Da
82 [GO] 2023―Feb―15 Conformational Ensemble of the NSP1 CTD in SARS-Cov2: Perspectives from the Free Energy Landscape Pallab Dutta, Abhay Kshirsagar, Parth Bibekar, Neelanjana Sengupta
83 [GO] 2023―Feb―10 Molecular mechanisms of cardiac complications associated with COVID-19 Steven R. Reiken, Haikel Dridi, Leah Sittenfeld, Yang Liu, Andrew R. Marks
84 [GO] 2023―Feb―10 SARS-CoV-2 spike protein-induced inflammation underlies proarrhythmia in COVID-19 Louisa Mezache, Gerard Nuovo, David Suster, Esmerina Tili, Hamdy Awad, Przemyslaw Radwanski, Rengasayee Veeraraghavan
85 [GO] 2023―Feb―10 Three-dimensional chromatin ensemble reconstruction via stochastic embedding reveals a missing link from COVID-19 infection to anosmia Igor N. Berezovsky
86 [GO] 2023―Feb―10 Comparison of three mathematical models for COVID-19 prediction Pelayo Martınez Fernandez, Zulima Fernandez-Muniz, Ana Cernea, Juan Luis Fernandez-Martınez, Andrzej Kloczkowski
87 [GO] 2023―Feb―10 Elucidating coronavirus fusion mechanisms Tobin Hess, Marcos Cervantes, Anjali Sengar, Peter Kasson
88 [GO] 2023―Feb―10 Polymer modelling accurately predicts three-dimensional chromosome reorganization with a seasonal coronavirus infection Ankush Singhal, Cullen Roth, Sofiya Micheva-Viteva, Anna Lappala, Jeannie T. Lee, Shawn R. Starkenburg, Karissa Y. Sanbonmatsu
89 [GO] 2023―Feb―10 Multicolor super-resolution imaging to study human coronavirus RNA during cellular infection Anish R. Roy, Jiarui Wang, Mengting Han, Haifeng Wang, Leonhard Möckl, Leiping Zeng, et al. (+2)
90 [GO] 2023―Feb―10 Natural effectors for conformational control of coronavirus spike proteins Daniel Asarnow, David Veesler
91 [GO] 2023―Feb―10 Analysis of the conserved and mutated amino acid sequences in the spike protein enhances the understanding of phylognetic relationship among coronavirus variants from the wild type Asmaa Awan, Roshan Paudel
92 [GO] 2023―Feb―10 Integration of smFRET and molecular dynamics to characterize conformational dynamics of the spike protein of wild-type SARS-CoV-2 and its variants Joseph Williamson, Maolin Lu, Mahmoud Moradi
93 [GO] 2023―Feb―10 Ascertaining mesoscopic parameters for SARS-CoV-2 assembly from all atom and coarse-grained simulations of the associated membrane protein Joseph McTiernan, Ajay Gopinathan, Michael E. Colvin
94 [GO] 2023―Feb―10 Understanding the mechanisms of increased pathogenicity and virulence of SARS-CoV-2 Delta and Omicron variants Mandira Dutta, Gregory A. Voth
95 [GO] 2023―Feb―10 Comparing elastic and molecular models of membrane bending local to SARS-CoV-2 envelope protein for mechanistic understanding Jesse W. Sandberg, Grace H. Brannigan
96 [GO] 2023―Feb―10 Ion channels activity of SARS-CoV-2 envelope protein through calcium influx assay using large unilamellar vesicles Hyejin Jeong
97 [GO] 2023―Feb―10 Identification and characterization of E266Q mutation in Nsp15 endoribonuclease from SARS-CoV-2 Epsilon variant Manashi Sonowal, Nirupa Nagaratnam, Rebecca J. Jernigan, Dhenugen Logeswaran, Raimund Fromme, Julian J.-L. Chen, Petra Fromme
98 [GO] 2023―Feb―10 The SARS-CoV-2 fusion domain preferentially initiates fusion in the late endosome Daniel Birtles, Jinwoo Lee
99 [GO] 2023―Feb―10 Single-molecule assay for highly sensitive SARS-CoV-2 gene detection based on CRISPR-Cas12a Sangmin Ji, Hye Ran Koh
100 [GO] 2023―Feb―10 Structure of SARS-CoV-2 M protein in lipid nanodiscs Kimberly A. Dolan, Mandira Dutta, David Kern, Abhay Kotecha, Gregory A. Voth, Steve Brohawn
101 [GO] 2023―Feb―10 Computational fragment screening of dimeric SARS-CoV-2 main protease Rashad L. Reid, Vincent Voelz
102 [GO] 2023―Feb―10 The conformational space of the SARS-CoV-2 main protease active site loops is determined by ligand binding and interprotomer allostery Ethan Lee, Sarah Rauscher
103 [GO] 2023―Feb―10 A genetically encoded BRET-based SARS-CoV-2 main protease activity sensor Anupriya M. Geethakumari, Wesam S. Ahmed, Saad Rasool, Asma Fatima, S. M. Nasir Uddin, Mustapha Aouida, Kabir H. Biswas
104 [GO] 2023―Feb―10 Dynamics of the SARS-CoV-2 main protease binding site Advaith S. Harith, Sacha Mallalieu, Amelia A. Fuller, Michelle E. McCully
105 [GO] 2023―Feb―10 Inhibition of the SARS-CoV-2 main protease by a thiadiazolidinone derivative Katarina Jovic, Logan Brown, Harish Vashisth, Krisztina Varga
106 [GO] 2023―Feb―10 Small molecule co-solvents enhance activity of SARS-CoV-2 main protease through a dielectric effect Marquise G. Crosby
107 [GO] 2023―Feb―10 Drug discovery targeting SARS-CoV-2 membrane fusion Kailu Yang, Chuchu Wang, Alex J.B. Kreutzberger, Ravi Ojha, Suvi Kuivanen, Sergio Couoh-Cardel, et al. (+9)
108 [GO] 2023―Feb―10 Identifying and sampling conformational states of SARS-CoV-2 mpro for flexible receptor docking Matthew S. Smith, Michael Grabe, Brian Shoichet
109 [GO] 2023―Feb―10 Studies on antiviral resistant SARS-CoV-2 Mpro mutants Morgan A. Esler, Arad Moghadasi, Reuben S. Harris, Hideki Aihara
110 [GO] 2023―Feb―10 SARS-CoV-2 Nsp3 oligomerization is a driver for molecular pore formation Yulia Pustovalova, Alexandra Pozhidaeva, Jeffrey C. Hoch
111 [GO] 2023―Feb―10 Dual functions of the SARS-CoV-2 nucleocapsid domains mediate RNA binding and phase separation Aidan B. Estelle, Zhen Yu, Patrick Allen, Elisar J. Barbar
112 [GO] 2023―Feb―10 Measuring DNA folding by the SARS-CoV-2 nucleocapsid protein Jake J. Kim, Youna N. Choi, Ashley R. Carter
113 [GO] 2023―Feb―10 Single-molecule spectroscopy of the SARS-CoV-2 nucleocapsid protein Jasmine Cubuk, Jeremias Incicco, Jhullian J. Alston, Kathleen B. Hall, Melissa D. Stuchell-Brereton, Andrea Soranno
114 [GO] 2023―Feb―10 Structure and function of SARS-CoV-2 nucleocapsid protein measured using optical tweezers, confocal fluorescence, and AFM Michael Morse, Jana Sefcikova, Micah J. McCauley, Ioulia F. Rouzina, Penny J. Beuning, Mark C. Williams
115 [GO] 2023―Feb―10 Combining simulations and single-molecule fluorescence spectroscopy to understand SARS-CoV-2 nucleocapsid protein RNA interaction Jhullian J. Alston, Jasmine Cubuk, Jeremias Incicco, Melissa D. Stuchell-Brereton, Kathleen B. Hall, Alex S. Holehouse, Andrea Soranno
116 [GO] 2023―Feb―10 Phase separation underlies interactions of the SARS-CoV-2 nucleocapsid protein with nucleoli Priyanka Dogra, Hazheen Shirnekhi, Mylene C. Ferrolino, Michele Tolbert, Cheon-Gil Park, Richard W. Kriwacki
117 [GO] 2023―Feb―10 The unique q493r mutation drives interfacial interactions in the SARS-CoV-2 Omicron variant S1-RBD: ACE2-complex Angelin M. Philip
118 [GO] 2023―Feb―10 Mechanism of assembly of an elongation-competent SARS-CoV-2 replication transcription complex Misha Klein, Subhas C. Bera, Thomas K. Anderson, Bing Wang, Flavia S. Papini, Jamie J. Arnold, et al. (+5)
119 [GO] 2023―Feb―10 Structural and thermodynamic consequences of the G31U and U5C mutations in the SARS-CoV-2 s2m Adam H. Kensinger, Joseph A. Makowski, Kendy A. Pellegrene, Caylee L. Cunningham, Caleb J. Frye, Patrick E. Lackey, et al. (+2)
120 [GO] 2023―Feb―10 Delta variant versus ancestral SARS-CoV-2 s2m dynamics and relative entropy Joseph A. Makowski, Adam H. Kensinger, Kendy A. Pellegrene, Caylee Cunningham, Caleb J. Frye, Patrick E. Lackey, et al. (+2)
121 [GO] 2023―Feb―10 The molecular basis for dysfunctional bacterial lipopolysaccharide-mediated immune receptor activation by SARS-CoV-2 spike Firdaus Samsudin, Venkata Raghuvamsi Palur, Ganna Petruk, Manoj Puthia, Jitka Petrlova, Paul MacAry, et al. (+3)
122 [GO] 2023―Feb―10 Post-translational modifications optimize the ability of SARS-CoV-2 spike for effective interaction with host cell receptors Tianle Chen, Karan Kapoor, Emad Tajkhorshid
123 [GO] 2023―Feb―10 SARS-CoV-2 spike opening dynamics and energetics reveal the individual roles of glycans and their collective impact Yui Tik Pang, Atanu Acharya, Diane L. Lynch, Anna Pavlova, James C. Gumbart
124 [GO] 2023―Feb―10 Single-molecule studies of RNA aptamers binding to SARS-CoV-2 spike proteins expressed on virus-like particles Brett Israels, Aleksandra Bednarz, Julian Valero Molero, Laia Civit Pitarch, Daniel Dupont, Mette Malle, et al. (+2)
125 [GO] 2023―Feb―10 Stabilized SARS-CoV-2 spike S2 immunogens designed using insights from enhanced sampling molecular dynamics simulations Xandra Nuqui, Lorenzo Casalino, Mohamed Shehata, Anupam A. Ojha, Fiona L. Kearns, Mia Rosenfeld, et al. (+2)
126 [GO] 2023―Feb―10 Design of immunogens for eliciting antibody responses that may protect against SARS-CoV-2 variants Eric Wang, Arup K. Chakraborty
127 [GO] 2023―Feb―10 Timeline of changes in spike conformational dynamics in emergent SARS-CoV-2 variants reveal progressive stabilization of trimer stalk and enhanced NTD dynamics Ganesh S. Anand, Sean Braet, Theresa Buckley, Varun Venkatakrishnan, Kim-Marie Dam, Pamela J. Bjorkman
128 [GO] 2023―Feb―10 Viral-host RNA-RNA interactions in SARS-CoV-2: Study of miR-34a-5p binding interactions within the genome 3'-untranslated region Caleb J. Frye, Caylee Cunningham, Adam H. Kensinger, Joseph A. Makowski, Jeffrey D. Evanseck, Mihaela-Rita Mihailescu
129 [GO] 2023―Jan―16 Interactions of SARS-CoV-2 and MERS-CoV Fusion Peptides Measured Using Single Molecule Force Methods Cindy Qiu, Gary R. Whittaker, Samuel H. Gellman, Susan Daniel, Nicholas L. Abbott
130 [GO] 2022―Nov―17 Structural Effects of Spike Protein D614G Mutation in SARS-CoV-2 Hisham M. Dokainish, Yuji Sugita
131 [GO] 2022―Aug―28 Circulating cell clusters aggravate the hemorheological abnormalities in COVID-19 Elahe Javadi, He Li, Ander Dorken Gallastegi, Galit H. Frydman, Safa Jamali, George Em Karniadakis
132 [GO] 2022―Mai―20 Finite element modeling of alpha-helices and tropocollagen molecules with reference to the spike of SARS-CoV-2 Tomasz Wierzbicki, Yuanli Bai
133 [GO] 2022―Apr―07 Role of spatial patterning of N-protein interactions in SARS-CoV-2 genome packaging Ian Seim, Christine A. Roden, Amy S. Gladfelter
134 [GO] 2022―Apr―02 Modeling insights into SARS-CoV-2 respiratory tract infections prior to immune protection Alexander Chen, Timothy Wessler, Katherine Daftari, Kameryn Hinton, Richard C. Boucher, Raymond Pickles, et al. (+3)
135 [GO] 2022―Feb―11 Developing drugs against essential proteins of SARS-CoV-2 for the treatment of COVID-19 Teena Bajaj
136 [GO] 2022―Feb―11 Predictive mathematical models of the growth of the COVID-19 pandemic Juan Luis Fernández-Martínez, Zulima Fernández-Muñiz, Ana Cernea, Andrzej Kloczkowski
137 [GO] 2022―Feb―11 A year in the life of SARS-CoV-2 Mpro: molecular modeling and analysis of clinically observed Mpro variants from the first year of the COVID-19 pandemic Elizabeth M. Diessner, Gemma R. Takahashi, Thomas J. Cross, Carter T. Butts, Rachel W. Martin
138 [GO] 2022―Feb―11 Catalytic function and substrate specificity of alpha and beta coronavirus papain-like proteases: targeting human NL63, SARS-CoV and SARS-CoV-2 (Covid-19) with designed inhibitors Mackenzie E. Chapman, Courtney M. Daczkowski, Arun K. Ghosh, Andrew D. Mesecar
139 [GO] 2022―Feb―11 Quantitative analysis of hypericin interaction with SARS-CoV 2 and with a model membrane Matteo Mariangeli, Eleonora Uriati, Chantal Usai, Andrea Mussini, Samira Jadavi, Silvia Dante, et al. (+7)
140 [GO] 2022―Feb―11 Structural dynamic changes in the SARS-CoV and SARS-CoV-2 S spike assemblies upon ACE2 activation Chengbo Chen, James B. Munro, Kelly K. Lee
141 [GO] 2022―Feb―11 Structural and dynamical impact of the two-nucleotide difference in sequence between SARS-CoV and SARS-CoV-2 s2m using molecular dynamics Adam H. Kensinger, Kendy A. Pellegrene, Joseph A. Makowski, Caylee L. Cunningham, Caleb J. Frye, Mihaela-Rita Mihailescu, Jeffrey D. Evanseck
142 [GO] 2022―Feb―11 Characterizing the roles of chemo-mechanical couplings in the differential behavior of SARS-CoV-1 and SARS-CoV-2 spike glycoprotein Ugochi H. Isu, Vivek Govind Kumar, Mortaza Derakhshani-Molayousefi, Adithya Polasa, Mahmoud Moradi
143 [GO] 2022―Feb―11 Automated refinement protocol to improve the quality of protein structures deposited in the protein data bank, applied to SARS-Cov-2 Joseph Farrell, Esmael J. Haddadian
144 [GO] 2022―Feb―11 Stem-loop II motif (s2m) structural and dynamical differences between SARS-CoV-2 and b.1.617.2 (Delta) variant Joseph A. Makowski, Adam H. Kensinger, Kendy A. Pellegrene, Caylee Cunningham, Caleb J. Frye, Morgan Shine, et al. (+4)
145 [GO] 2022―Feb―11 The discovery of antivirals and novel targets for SARS-CoV-2 and EV-A71 Christina Haddad, Blanton S. Tolbert, Amanda E. Hargrove, Gary Brewer, Mei-Ling Li
146 [GO] 2022―Feb―11 Structural dynamics of prefusion spike protein of SARS-CoV-2 and its variants Mortaza Derakhshani-Molayousefi, Ugochi Isu, Mahmoud Moradi
147 [GO] 2022―Feb―11 SARS-CoV-2 antibodies specific to the mesa and inner side of spike protein receptor binding domain maintain high affinities for both D614G and b.1.351 variants Kan Li, Richard H.C. Huntwork, Gillian Q. Horn, Elizabeth Feeney, Kathryn M. Hastie, Haoyang Li, et al. (+9)
148 [GO] 2022―Feb―11 Characterization of the S2M G15U mutation associated with the SARS-CoV-2 delta variant Caylee L. Cunningham, Caleb J. Frye, Joshua A. Imperatore, Kendy A. Pellegrene, Adam H. Kensinger, Joseph A. Makowski, et al. (+4)
149 [GO] 2022―Feb―11 Changes in the receptor-binding interface may cause immune evasion by the SARS-CoV-2 delta variant b.1.617.2 Prabin Baral, Nisha Bhattarai, Md Lokman Hossen, Vitalii Stebliankin, Bernard S. Gerstman, Giri Narasimhan, Prem P. Chapagain
150 [GO] 2022―Feb―11 Impact of mutations near the SARS-CoV-2 furin-cleavage site on viral infectivity Kien Nguyen, Srirupa Chakraborty, Pedro D. Manrique, Bette Korber, S. Gnanakaran
151 [GO] 2022―Feb―11 The spike-ACE2 interaction underlying SARS-CoV-2 infection and inhibition is enhanced by intermolecular cross linking Roi Asor, Anna Olerinyova, Manish S. Kushwah, Fabian Soltermann, Lucas Powell Rudden, SnezÌŒana Vasiljevic, et al. (+7)
152 [GO] 2022―Feb―11 Computational investigation of glycosaminoglycan cofactors in SARS-CoV-2 infection dynamics Mia A. Rosenfeld, Fiona L. Kearns, Sang Hoon Kim, Lorenzo Casalino, Micah Papanikolas, Carlos Simmerling, et al. (+2)
153 [GO] 2022―Feb―11 Developing inhibitors of the SARS-CoV-2 main protease Christian Seitz, Vedran Markota, Terra Sztain-Pedone, Morgan Esler, Arad Moghadasi, Samantha Kennelly, et al. (+6)
154 [GO] 2022―Feb―11 Dimethyl sulfoxide (DMSO) affects activity of SARS-CoV-2 main protease Marquise G. Crosby, Gemma R. Takahashi, Rachel W. Martin, Elizabeth Diessner, Brenna Norton-Baker, Carter T. Butts
155 [GO] 2022―Feb―11 Comprehensive virtual screening of 4.8k flavonoids reveals novel insights into the allosteric inhibition of SARS-CoV-2 MPRO Ana Paula Vargas Ruiz, Gabriel Jiménez Avalos, Nicolás E. Delgado, Gustavo Olivos Ramírez, Patricia Sheen, Miguel Quiliano, Mirko Zimic
156 [GO] 2022―Feb―11 Binding and compaction function of structural domains of SARS-CoV-2 nucleocapsid (N) protein on a single stranded nucleic acid substrate Michael Morse, Jana Sefcikova, Ioulia Rouzina, Penny J. Beuning, Mark C. Williams
157 [GO] 2022―Feb―11 Characterizing nucleic acid interactions with the N-Terminal binding domain of the SARS-CoV-2 nucleocapsid protein Jasmine Cubuk, Juan J. Incicco, Melissa D. Stuchell-Brereton, Kathleen B. Hall, Andrea Soranno
158 [GO] 2022―Feb―11 SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA Amanda Jack, Luke Ferro, Michael J. Trnka, Eddie Wehri, Amrut Nadgir, Xammy Nguyenla, et al. (+5)
159 [GO] 2022―Feb―11 Investigating SARS-CoV-2 ORF7a and BST-2 heterodimerization by molecular dynamics simulations Min-Kang Hsieh, Jeffery B. Klauda
160 [GO] 2022―Feb―11 Comparing structural ensembles with DiffNets helps explain the activation mechanism of the SARS-CoV-2 protein NSP16 Michael D. Ward
161 [GO] 2022―Feb―11 Cryo-electron tomography of in vivo reconstituted SARS-CoV-2 replication/transcription organelles Cosmo Z. Buffalo, James H. Hurley
162 [GO] 2022―Feb―11 Single molecule activity assay for SARS-CoV-2 RNA dependent RNA polymerase SangYoon Chung, Yazan Alhadid, Maya Segal, Jookyung Lee, Sergei Borukhov, Shimon Weiss
163 [GO] 2022―Feb―11 Probing remdesivir nucleotide analogue insertion to SARS-CoV-2 RNA dependent RNA polymerase in viral replication Moises E. Romero, Chunhong Long, Daniel La Rocco, Anusha M. Keerthi, Dajun Xu, Jin Yu
164 [GO] 2022―Feb―11 Molecular mechanism for conformational activation of SARS-CoV-2 RNA polymerase by nucleoside triphosphate Wen Ma, J. Andrew McCammon
165 [GO] 2022―Feb―11 SARS-CoV-2 S1 spike protein peptides inhibit alpha 7 nAChRs and are counteracted by a PAM at alpha 7 Joseph Farley, Jonathan B. Anderson
166 [GO] 2022―Feb―11 Decreased interfacial dynamics caused by the N501Y mutation in the SARS-Cov-2 s1 spike:ACE2 complex Wesam S. Ahmed, Angelin M. Philip, Kabir H. Biswas
167 [GO] 2022―Feb―11 A high throughput method for ensemble antibody affinity measurements for SARS-CoV-2 samples Gabrielle Kosoy, Abdul Karim, Phuong Nguyen, Mark Sangster, David Topham, Benjamin Miller
168 [GO] 2022―Feb―11 Probing key interactions between SARS-CoV-2 spike and heparan sulfate Fiona L. Kearns, Mia Rosenfeld, Sang Hoon Kim, Lorenzo Casalino, Micah Papanikolas, Carlos Simmerling, et al. (+2)
169 [GO] 2022―Feb―11 SARS-CoV-2 spike binding to ACE2 is stronger and longer ranged with glycans Yihan Huang, Bradley Harris, Shiaki Minami, Seongwon Jung, Priya Shah, Somen Nandi, et al. (+2)
170 [GO] 2022―Feb―11 Conformational changes in SARS-CoV-2 spike from the delta variant enhances viral transmissibility Varun Venkatakrishnan, Sean Braet, Theresa Buckley, Ganesh S. Anand
171 [GO] 2022―Feb―11 Computational studies of the dynamics of SARS-CoV-2 spike, membrane, and nucleocapsid proteins Mandira Dutta, Gregory A. Voth
172 [GO] 2022―Feb―11 Concerted hinge motions in SARS-CoV-2 spike modulated by glycan-glycan and glycan-lipid interactions Karan Kapoor, Tianle Chen, Emad Tajkhorshid
173 [GO] 2022―Feb―11 Ensemble-based, glycan-dependent epitope analysis of SARS-CoV-2 spike protein Tianle Chen, Karan Kapoor, Emad Tajkhorshid
174 [GO] 2022―Feb―11 Computationally engineered ACE2 decoy binds with nanomolar affinity with the SARS-CoV-2 spike protein Mohammad S. Islam, Brandon Havranek, Erik Procko, Kui Chan
175 [GO] 2022―Feb―11 The roles of glycans in the SARS-CoV-2 spike protein Lorenzo Casalino, Rommie E. Amaro
176 [GO] 2022―Feb―11 Unraveling SARS-CoV-2 spike protein activation pathway reveals unprecedented cryptic pockets Hisham M. Dokainish, Suyong Re, Takaharu Mori, Chigusa Kobayashi, Jaewoon Jung, Yuji Sugita
177 [GO] 2022―Feb―11 Machine learning reveals the critical interactions for SARS-CoV-2 spike protein binding to ACE2 Anna Pavlova, Zijian Zhang, Atanu Acharya, Diane L. Lynch, Yui Tik Pang, Zhongyu Mou, et al. (+3)
178 [GO] 2022―Feb―11 Elucidating the distinct structural features of the SARS-CoV-2 spike protein fusion domain Daniel Birtles
179 [GO] 2022―Feb―11 Host cell membrane capture by the SARS-CoV-2 spike protein fusion intermediate Rui Su, Jin Zeng, Ben O'Shaughnessy
180 [GO] 2022―Feb―11 Impact of SARS-CoV-2 spike protein on α7 nicotinic acetylcholine receptor in cells Tommy S. Tillman, Yan Xu, Pei Tang
181 [GO] 2022―Feb―11 The SARS-CoV-2 spike protein reversibly samples an open-trimer conformation exposing novel epitopes Sophie R. Shoemaker, Shawn M. Costello, Helen T. Hobbs, Annalee W. Nguyen, Ching-Lin Hsieh, Jennifer A. Maynard, et al. (+3)
182 [GO] 2022―Feb―11 Intricacies of the SARS-CoV-2 spike transmembrane trimer organization Elena T. Aliper, Nikolay A. Krylov, Anton A. Polyansky, Roman G. Efremov
183 [GO] 2022―Feb―11 Whole-cell quantitative imaging of structural changes induced by SARS-CoV-2 using soft X-ray tomography Jian-Hua Chen, Valentina Loconte, Mirko Cortese, Axel Ekman, Mark A. Le Gros, Ralf Bartenschlager, et al. (+2)
184 [GO] 2022―Feb―11 AI-Driven prediction of binding trends of SARS-CoV-2 variants from atomistic simulations Sara Capponi, Shangying Wang, Erik Navarro, Simone Bianco
185 [GO] 2022―Feb―11 Differential interactions between human ACE2 and spike RBD of SARS-CoV-2 variants of concern Seonghan Kim, Yi Liu, Zewei Lei, Jeffrey Dicker, Yiwei Cao, Xiaohui Zhang, Wonpil Im
186 [GO] 2022―Feb―11 SARS-Cov-2 variants of concern decelerate the dynamics of spike open conformation as an evolutionary strategy Ziwei Yang, Yang Han, Shilei Ding, Andrés Finzi, Walther Mothes, Maolin Lu
187 [GO] 2022―Feb―11 Structure, dynamics and nanomechanics of wild-type and alpha-variant SARS-CoV-2 virions Dorottya Mudra, Balint Kiss, Zoltán Kis, Bernadett Pályi, Miklós Kellermayer
188 [GO] 2022―Feb―11 Development of a SARS-CoV-2 virus-like particle that performs as a direct cell entry reporter Elena Mekhedov, Matthias Garten, Glen Humphrey, Jennifer D. Petersen, Adriana E. Golding, Hang Waters, Joshua Zimmerberg
189 [GO] 2022―Feb―11 Preparation of SARS-CoV-2 VLP to study viral assembly, egress, and entry Jennifer D. Petersen, Glen Humphrey, Elena Mekhedov, Hang Waters, Joshua Zimmerberg
190 [GO] 2022―Feb―11 Expression of SARS-CoV-2-ORF3a protein induces cardiomyocyte damage Iuliia A. Polina, Yugene Guo, Michael W. Cypress, Elena G. Tolkacheva, Bong Sook Jhun, Jin O-Uchi
191 [GO] 2022―Feb―11 Viral-host RNA-RNA interactions in SARS-CoV-2: study of MIR-760-3p interactions with the genome 3'-untranslated region Caleb J. Frye, Caylee L. Cunningham, Kendy A. Pellegrene, Adam H. Kensinger, Joseph A. Makowski, Jeffrey D. Evanseck, Mihaela-Rita Mihailescu
192 [GO] 2022―Feb―11 A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions Magnus S. Bauer, Sophia Gruber, Adina Hausch, Lukas F. Milles, Thomas Nicolaus, Leonard C. Schendel, et al. (+6)
193 [GO] 2022―Feb―11 Developing lectins as inhibitors of SARS-CoV2 Alex J. Guseman, Linda Murphy, Sham Nambulli, Fatema Bhinderwhala, Paul Duprex, Angela M. Gronenborn
194 [GO] 2021―Dez―18 Importance of Negatively Charged Residues in the Membrane Ordering Activity of SARS-CoV-1 and -2 Fusion Peptides Alex L. Lai, Jack H. Freed
195 [GO] 2021―Dez―07 SARS-Cov-2 Spike binding to ACE2 is stronger and longer ranged due to glycan interaction Yihan Huang, Bradley S. Harris, Shiaki A. Minami, Seongwon Jung, Priya S. Shah, Somen Nandi, et al. (+2)
196 [GO] 2021―Nov―10 Modeling Coronavirus Spike Protein Dynamics: Implications for Immunogenicity and Immune Escape G. Kunkel, M. Madani, S.J. White, P.H. Verardi, A. Tarakanova
197 [GO] 2021―Okt―28 More pandemic reflections H. Jane Dyson
198 [GO] 2021―Jul―31 “Bucket brigade” using lysine residues in RNA-dependent RNA polymerase of SARS-CoV-2 Shoichi Tanimoto, Satoru G. Itoh, Hisashi Okumura
199 [GO] 2021―Jul―14 Biophysicists’ continued outstanding response to COVID-19 Tamar Schlick, Eric J. Sundberg, Susan J. Schroeder, M. Madan Babu
200 [GO] 2021―Jun―30 Role of spatial patterning of N-protein interactions in SARS-CoV-2 genome packaging Ian Seim, Christine A. Roden, Amy S. Gladfelter
201 [GO] 2021―Jun―29 Regulation of epithelial sodium channel activity by SARS-CoV-1 and SARS-CoV-2 proteins Stephen N. Grant, Henry A. Lester
202 [GO] 2021―Jun―29 Transient complexes of the Nsp7, Nsp8 and Nsp12 in SARS-CoV-2 replication transcription complex Mateusz Wilamowski, Michal Hammel, Wellington Leite, Qiu Zhang, Youngchang Kim, Kevin Weiss, et al. (+11)
203 [GO] 2021―Jun―29 Dynamics of the SARS-CoV-2 nucleoprotein N-terminal domain triggers RNA duplex destabilization Ícaro P. Caruso, Karoline Sanches, Andrea T. Da Poian, Anderson S. Pinheiro, Fabio C.L. Almeida
204 [GO] 2021―Jun―02 Physical phenotype of blood cells is altered in COVID-19 Markéta Kubánková, Bettina Hohberger, Jakob Hoffmanns, Julia Fürst, Martin Herrmann, Jochen Guck, Martin Kräter
205 [GO] 2021―Jun―02 Neuropilin-1 Assists SARS-CoV-2 Infection by Stimulating the Separation of Spike Protein Domains S1 and S2 Li Zhen-lu, Buck Matthias
206 [GO] 2021―Jun―02 Enhanced Sampling Protocol to Elucidate Fusion Peptide Opening of SARS-CoV-2 Spike Protein Jacob M. Remington, Kyle T. McKay, Jonathon B. Ferrell, Severin T. Schneebeli, Jianing Li
207 [GO] 2021―Mai―11 Computational optimization of the SARS-CoV-2 receptor-binding-motif affinity for human ACE2 Savvas Polydorides, Georgios Archontis
208 [GO] 2021―Mrz―29 Multivalent binding of the partially disordered SARS-CoV-2 nucleocapsid phosphoprotein dimer to RNA Heather M. Forsythe, Joaquin Rodriguez Galvan, Zhen Yu, Seth Pinckney, Patrick Reardon, Richard B. Cooley, et al. (+4)
209 [GO] 2021―Mrz―29 SARS-CoV2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential Neha Vithani, Michael D. Ward, Maxwell I. Zimmerman, Borna Novak, Jonathan H. Borowsky, Sukrit Singh, Gregory R. Bowman
210 [GO] 2021―Mrz―09 Exploring dynamics and network analysis of spike glycoprotein of SARS-COV-2 Mahdi Ghorbani, Bernard R. Brooks, Jeffery B. Klauda
211 [GO] 2021―Mrz―04 Biophysicists' outstanding response to Covid-19 Tamar Schlick, Eric J. Sundberg, Susan J. Schroeder, M. Madan Babu
212 [GO] 2021―Mrz―04 Principles and Practice for SARS-CoV-2 Decontamination of N95 Masks with UV-C Thomas Huber, Olivia Goldman, Alexander E. Epstein, Gianna Stella, Thomas P. Sakmar
213 [GO] 2021―Mrz―04 Binding Mode of SARS-CoV2 Fusion Peptide to Human Cellular Membrane Defne Gorgun, Muyun Lihan, Karan Kapoor, Emad Tajkhorshid
214 [GO] 2021―Feb―23 Ca2+-dependent mechanism of membrane insertion and destabilization by the SARS-CoV-2 fusion peptide George Khelashvili, Ambrose Plante, Milka Doktorova, Harel Weinstein
215 [GO] 2021―Feb―18 A potential interaction between the SARS-CoV-2 spike protein and nicotinic acetylcholine receptors A. Sofia F. Oliveira, Amaurys Avila Ibarra, Isabel Bermudez, Lorenzo Casalino, Zied Gaieb, Deborah K. Shoemark, et al. (+4)
216 [GO] 2021―Feb―17 Biomechanical Characterization of SARS-CoV-2 Spike RBD and Human ACE2 Protein-Protein Interaction Wenpeng Cao, Chuqiao Dong, Seonghan Kim, Decheng Hou, Wanbo Tai, Lanying Du, et al. (+2)
217 [GO] 2021―Feb―12 Hydrating the Respiratory Tract: An Alternative Explanation Why Masks Lower Severity of COVID-19 Joseph M. Courtney, Ad Bax
218 [GO] 2021―Feb―12 Vitamin D and Its Derivatives as Promising Drugs Against COVID-19 - A Computational Study Yuwei Song, Shariq Qayyum, Radomir Slominski, Chander Raman, Andrzej Slominski, Yuhua Song
219 [GO] 2021―Feb―12 Rationally Designed Chimeric Antibodies for COVID-19 and Future Coronavirus Variants Ching-chung Hsueh, Steven S. Plotkin
220 [GO] 2021―Feb―12 COVID-19 Drugs Chloroquine and Hydroxychloroquine, but Not Azithromycin and Remdesivir, Block hERG Potassium Channels Mark Szendrey, Jun Guo, Wentao Li, Tonghua Yang, Shetuan Zhang
221 [GO] 2021―Feb―12 Investigational Treatments for COVID-19 May Increase Ventricular Arrhythmia Risk through Drug Interactions Meera Varshneya, Itziar Irurzun-Arana, Chiara Campana, Rafael Dariolli, Amy Gutierrez, Taylor K. Pullinger, Eric A. Sobie
222 [GO] 2021―Feb―12 Introductory Models of the Covid-19 Pandemic in the United States Peter H. Nelson
223 [GO] 2021―Feb―12 Identification of FDA Approved Antiviral Drugs for COVID-19 Treatment using Unbiased Virtual Screening Rory Greer, Yuwei Song, Michael J. Patton, Matthew Might, Kevin Harrod, Chad M. Petit, Yuhua Song
224 [GO] 2021―Feb―12 Coronavirus Envelope Protein: Lipid Sensitivity and Membrane Bending Jesse Sandberg, Grace H. Brannigan
225 [GO] 2021―Feb―12 Coronavirus Pathogenicity is Determined by Stability of the Spike Protein Open Conformation Josiah Bones, Ben Corry
226 [GO] 2021―Feb―12 Modeling and Manipulating Antibody Response Against Influenza and Coronavirus Spike Proteins and Exploring their Role in Directing Spike Evolution Assaf Amitai, Maya Sangesland, Daniel Lingwood, Arup K. Chakraborty
227 [GO] 2021―Feb―12 Anti-Frameshifting Ligand Active against SARS Coronavirus-2 is Resistant to Natural Mutations of the Frameshift-Stimulatory Pseudoknot Krishna Neupane, Sneha Munshi, Meng Zhao, Dustin Ritchie, Sandaru M. Ileperuma, Michael T. Woodside
228 [GO] 2021―Feb―12 Differential Dynamic Behavior of Prefusion Spike Glycoproteins of Sars Coronaviruses 1 and 2 Mahmoud Moradi, Vivek Govind Kumar, Dylan S. Ogden, Ugochi Isu, James Losey
229 [GO] 2021―Feb―12 Distinct Differences in the Interactions of Receptor Binding Domains of SARS-CoV-2 and SARS-CoV with Human ACE2 Atanu Acharya, Anna Pavlova, Christophe J. Chipot, James C. Gumbart
230 [GO] 2021―Feb―12 An Integrative MD Simulation and Network Analysis Approach to Study Glycosylation of Spike in SARS-CoV-2 Mahdi Ghorbani, Bernard R. Brooks, Jeffery B. Klauda
231 [GO] 2021―Feb―12 Combining Computational Modeling with Library Screening to Adapt SARS-CoV-Neutralizing Antibody 80R to SARS-CoV-2 Michael S. Kent, Maxwell Stefan, Kenneth Sale, Corey Hudson, Daniella Martinez, Miranda Juarros, et al. (+5)
232 [GO] 2021―Feb―12 Modeling Protein-Lipid Interactions during Viral Assembly of SARS-CoV-2 Viviana Monje-Galvan, Alexander Pak, Gregory A. Voth
233 [GO] 2021―Feb―12 Adaptive Evolution of Peptide Inhibitors for Mutating SARS-CoV-2 Parth Chaturvedi, Yanxiao Han, Petr Král, Lela Vukovic
234 [GO] 2021―Feb―12 Quantitative Fluorescence Microscopy on SARS-CoV-2 Rayna M. Addabbo, John Kohler, Isaac Angert, Yan Chen, Heather Hanson, Louis M. Mansky, Joachim D. Mueller
235 [GO] 2021―Feb―12 The Effect of Glycans Steric Potentials on Virus Infectivity- the SARS-Cov-2 Case Giuseppe Battaglia
236 [GO] 2021―Feb―12 Characterization of SARS-CoV-2 Conserved Elements’ Structures and their RNA-RNA Interactions Caylee Cunningham, Joshua Imperatore, Ella Milback, Morgan Shine, Kendy A. Pellegrene, Patrick Lackey, et al. (+2)
237 [GO] 2021―Feb―12 Structural Dynamics of SARS-CoV-2 Frameshift Signal Studied by Single-Molecule Force Spectroscopy Reveal Topologically Distinct Conformers Krishna P. Neupane, Meng Zhao, Noel Q. Hoffer, Aaron Lyons, Sneha Munshi, Dustin Ritchie, Michael T. Woodside
238 [GO] 2021―Feb―12 High-Coverage Nucleic Acid Probes for Distinguishing SARS-COV-2 from Influenza Samantha J. Courtney, Zachary R. Stromberg, James Theiler, Brian T. Foley, Jason D. Gans, Karina Yusim, Jessica Z. Kubicek-Sutherland
239 [GO] 2021―Feb―12 The Design of a Destabilizer Peptide to Disrupt SARS-CoV-2 Fusion with Its Targeted Cell Membrane Motamed Qadan
240 [GO] 2021―Feb―12 SARS-CoV-2 Glycosylated Spike Activation Mechanism - Simulations of the Full Unbiased Pathway Terra Sztain-Pedone, Surl-Hee Ahn, Anthony Bogetti, Lorenzo Casalino, Zied Gaieb, James A. McCammon, et al. (+2)
241 [GO] 2021―Feb―12 Inhibitor Binding Influences the Protonation State of Histidines in SARS-CoV-2 Main Protease Anna Pavlova, Diane L. Lynch, Micholas Dean Smith, Jeremy D. Smith, James C. Gumbart
242 [GO] 2021―Feb―12 The Effect of Point Mutations on Structure and Dynamics of SARS-CoV-2 Main Protease Mutants Elizabeth M. Diessner, Zixiao Zong, Thomas J. Cross, Gemma R. Takahashi, Marquise G. Crosby, Vesta Farahmad, et al. (+3)
243 [GO] 2021―Feb―12 Force-Dependent Stimulation of RNA Unwinding by SARS-CoV-2 NSP13 Helicase Keith J. Mickolajczyk, Patrick M. Shelton, Michael Grasso, Xiaocong Cao, Sara E. Warrington, Amol Aher, et al. (+2)
244 [GO] 2021―Feb―12 DNA Folding by the SARS-CoV-2 Nucleocapsid Protein Youna N. Choi, Ryan B. McMillan, Ashley R. Carter
245 [GO] 2021―Feb―12 Investigating SARS-CoV-2 Orf7B Homodimerization by Molecular Dynamics Simulations Min-Kang Hsieh, Jeffery B. Klauda
246 [GO] 2021―Feb―12 Dynamics and Binding Strength of the Spike Protein of Sars-Cov-2 Probed by High-Speed Atomic Force Microscopy Fidan Sumbul, Claire Valotteau, Ignacio Fernandez, Analisa Meola, Eduard Baquero, Dorota Kostrz, et al. (+4)
247 [GO] 2021―Feb―12 Automated Computational Technique to Improve the Quality of SARS-CoV-2 Proteins Joseph P. Farrell, Esmael J. Haddadian
248 [GO] 2021―Feb―12 Using Tactics to Find Druggable Pockets in SARS-CoV-2 Proteins Daniel J. Evans, Remy A. Yovanno, Sanim Rahman, Afif Bandak, Albert Y. Lau
249 [GO] 2021―Feb―12 Prediction and Analysis of Multiple Sites and Inhibitors of SARS-CoV-2 Proteins Suhasini M. Iyengar, Kelton Barnsley, Hoang Yen Vu, Ryan Dilworth, Jana Sefcikova, Penny Beuning, Mary Jo Ondrechen
250 [GO] 2021―Feb―12 Characterizing Binding Kinetics and Thermodynamics of Computer-Designed Nanobodies Targeting SARS-CoV-2 RBD Matheus Ferraz, Roberto Lins
251 [GO] 2021―Feb―12 Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2 Kien Nguyen, Srirupa Chakraborty, Rachael A. Mansbach, Pedro D. Manrique, Bette Korber, Sandrasegaram Gnanakaran
252 [GO] 2021―Feb―12 The Effect of Mutations on Binding Interactions Between the SARS-CoV-2 Receptor Binding Domain and Neutralizing Antibodies Jonathan E. Barnes, Peik K. Lund-Andersen, Jagdish S. Patel, F. Marty Ytreberg
253 [GO] 2021―Feb―12 Modeling the Structure of the Frameshift-Stimulatory Pseudoknot in SARS-CoV-2 Reveals Multiple Possible Conformers Sara Ibrahim Omar, Meng Zhao, Rohith Vedhthaanth Sekar, Sahar Arbabimoghadam, Jack A. Tuszynski, Michael T. Woodside
254 [GO] 2021―Feb―12 Energetics of Opening for the Glycosylated and Unglycosylated Forms of the SARS-CoV-2 S-Protein Trimer Yui Tik Pang, Atanu Acharya, Diane L. Lynch, James C. Gumbart
255 [GO] 2021―Feb―12 Enhanced Sampling of the SARS-CoV-2 s2m Element Adam H. Kensinger, Kendy A. Pellegrene, Joshua Imperatore, Matthew N. Srnec, Mihaela-Rita Mihailescu, Jeffrey D. Evanseck
256 [GO] 2021―Feb―12 Condensed Liquid Phase 3D Structure of SARS-CoV-2 s2m Guided by NMR Spectroscopy Kendy A. Pellegrene, Joshua A. Imperatore, Caylee L. Cunningham, Adam H. Kensinger, Petru Mihailescu, Matthew N. Srnec, et al. (+2)
257 [GO] 2021―Feb―12 SARS-CoV-2 Simulations go Exascale to Capture Spike Opening and Reveal Cryptic Pockets Across the Proteome Maxwell I. Zimmerman, Gregory Bowman
258 [GO] 2021―Feb―12 Essential Dynamics that Drive Sars-Cov-2 Spike Conformational Changes Srirupa Chakraborty, Rachael A. Mansbach, Kien Nguyen, Pedro D. Manrique, Sandrasegaram Gnanakaran
259 [GO] 2021―Feb―12 Identifying Hotspots in Binding of SARS-CoV-2 Spike Glycoprotein and Human ACE2 Jenny Mendis, Ekrem Kaya, Tugba G. Kucukkal
260 [GO] 2021―Feb―12 Inhibition of SARS-CoV-2 Spike Protein Function by Amphiphilic Block Copolymers Michelle X. Ling, Michelle Nguyen, Kyle McCollum, Raphael C. Lee
261 [GO] 2021―Feb―12 Refinement of the Transmembrane Domain in Constructing the Membrane-Embedded SARS-COV-2 Spike Protein Model Tianle Chen, Karan Kapoor, Emad Tajkhorshid
262 [GO] 2021―Feb―12 The Influence of Glycosylation on the Interaction of the Sars-Cov-2 Spike Protein Receptor Binding Domain with Therapeutic Candidates. Bradley Harris, Yihan Huang, Giovanni Lara, Shiaki Minami, Matthew Kenaston, Seongwon Jung, et al. (+5)
263 [GO] 2021―Feb―12 The Extended Intermediate of the SARS-CoV-2 Spike Protein uses Extreme Reach and Flexibility to Capture Host Cell Membranes Rui Su, Jin Zeng, Sathish Thiyagarajan, Ben O'Shaughnessy
264 [GO] 2021―Feb―12 Mapping Binding Interfaces and Allosteric Changes in the SARS-Cov-2 Spike Protein using Hydrogen/Deuterium Exchange Mass Spectrometry Shawn M. Costello, Helen T. Hobbs, Sophie R. Shoemaker, Abigail E. Powell, Shion A. Lim, James A. Wells, et al. (+3)
265 [GO] 2021―Feb―12 The SARS-CoV-2 Spike Variant D614G Favors an Open Conformational State Rachael A. Mansbach, Srirupa Chakraborty, Kien Nguyen, David C. Montefiori, Bette Korber, Gnana Gnanakaran
266 [GO] 2021―Feb―12 Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles Maolin Lu, Pradeep D. Uchil, Wenwei Li, Daniel S. Terry, Jason Gorman, Baoshang Zhang, et al. (+9)
267 [GO] 2021―Feb―12 Predicting the Ability of SARS-CoV-2 to Utilize the ACE2 Receptor for Cell Entry in North American Rodents Peik K. Lund-Andersen, Jeremy R. Ellis, James T. Van Leuven, Jagdish Patel
268 [GO] 2021―Feb―12 Understanding Activation and Inhibition of SARS-CoV-2 Viral Entry with Single-Virus Microscopy Anjali Sengar, Giorgio Morbioli, Peter Kasson
269 [GO] 2021―Feb―12 Topography, Spike Dynamics and Nanomechanics of Individual Native SARS-CoV-2 Virions Balint Kiss, Zoltán Kis, Bernadett Pályi, Miklós S. Kellermayer
270 [GO] 2021―Feb―12 Adaptive Evolution of SARS-CoV-2: A Perspective from Dynamics Ismail C. Kazan, S. Banu Ozkan
271 [GO] 2021―Feb―12 Conserved Elements in the 3'-UTR of SARS-CoV-2: Involvement in Genomic Dimerization and Interactions with Cellular Micrornas Joshua A. Imperatore, Caylee L. Cunningham, Caleb J. Frye, Kendy A. Pellegrene, Jeffrey D. Evanseck, Mihaela-Rita Mihailescu
272 [GO] 2021―Feb―12 Mechanism and Pathways of Inhibitor Binding to the Human ACE2 Receptor for SARS-CoV1/2 Apurba Bhattarai, Shristi Pawnikar, Yinglong Miao
273 [GO] 2021―Feb―12 Factors that Affect the Binding of the N-Terminal Helix of Human ACE2 to Spike Protein of SARS-CoV2 Anirban Das, Vicky Vishvakarma, Ankur Gupta, Simli Dey, Arpan Dey, U. Sandra, et al. (+5)
274 [GO] 2021―Feb―12 Elucidating the Mechanism of Membrane Destabilization by the Preferred Modes of Insertion of the Sars-Cov2 Fusion Peptide George Khelashvili, Harel Weinstein
275 [GO] 2021―Feb―12 Binding Mode of SARS-CoV2 Fusion Peptide to Human Cellular Membranes Defne Gorgun, Muyun Lihan, Karan Kapoor, Emad Tajkhorshid
276 [GO] 2021―Feb―12 Hepatitis C Virus Protease Inhibitors Suppress Virus Replication and Act Synergistically with the SARS-CoV2 Polymerase Inhibitor Remdesivir Khushboo Bafna, Kris White, Balasubramanian Harish, Catherine A. Royer, Adolfo Garcia-Sastre, Robert M. Krug, Gaetano T. Montelione
277 [GO] 2021―Feb―03 Bow to the Enemy: How Flexibility of Host Protein Receptors Can Favor SARS-CoV-2 Stefano A. Serapian, Giorgio Colombo
278 [GO] 2021―Feb―03 Graph, Pseudoknot, and SARS-Cov-2 Genomic RNA - a Biophysical Synthesis Shi-Jie Chen
279 [GO] 2021―Jan―26 A Multiscale Coarse-grained Model of the SARS-CoV-2 Virion John E. Straub
280 [GO] 2021―Jan―21 Elucidation of Interactions Regulating Conformational Stability and Dynamics of SARS-CoV-2 S-Protein Takaharu Mori, Jaewoon Jung, Chigusa Kobayashi, Hisham M. Dokainish, Suyong Re, Yuji Sugita
281 [GO] 2021―Jan―17 Improving SARS-CoV-2 Structures: Peer Review by Early Coordinate Release Tristan I. Croll, Christopher J. Williams, Vincent B. Chen, David C. Richardson, Jane S. Richardson
282 [GO] 2020―Dez―25 The molecular mechanism of domain-swapping of the C-terminal domain of the SARS coronavirus main protease Vishram L. Terse, Shachi Gosavi
283 [GO] 2020―Dez―17 Force-dependent stimulation of RNA unwinding by SARS-CoV-2 nsp13 helicase Keith J. Mickolajczyk, Patrick M.M. Shelton, Michael Grasso, Xiaocong Cao, Sara E. Warrington, Amol Aher, et al. (+2)
284 [GO] 2020―Nov―28 Thermal Inactivation Scaling Applied for SARS-CoV-2 Shahar Seifer, Michael Elbaum
285 [GO] 2020―Nov―28 A Multiscale Coarse-grained Model of the SARS-CoV-2 Virion Alvin Yu, Alexander J. Pak, Peng He, Viviana Monje-Galvan, Lorenzo Casalino, Zied Gaieb, et al. (+3)
286 [GO] 2020―Nov―13 The flexibility of ACE2 in the context of SARS-CoV-2 infection Emilia P. Barros, Lorenzo Casalino, Zied Gaieb, Abigail C. Dommer, Yuzhang Wang, Lucy Fallon, et al. (+4)
287 [GO] 2020―Okt―21 Structure-Altering Mutations of the SARS-CoV-2 Frame Shifting RNA Element Tamar Schlick, Qiyao Zhu, Swati Jain, Shuting Yan
288 [GO] 2020―Aug―08 Reflections on the Pandemic H. Jane Dyson
 [1] 

288 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.020 sec